In Vitro Evaluation of a Semisynthetic Derivative of Gentamicin B (SCH 21420)
AUTOR(ES)
Yu, Pauline K. W.
RESUMO
The activities of Sch 21420 and amikacin were compared in vitro against 448 clinical bacterial isolates and against 82 gentamicin-resistant isolates of gram-negative bacilli. At 1 μg/ml, Sch 21420 was more active than amikacin against most Enterobacteriaceae but less active against Pseudomonas aeruginosa. Activity of these antibiotics against gentamicin-resistant organisms varied according to the species examined.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352351Documentos Relacionados
- In Vitro Activity of Sch 21420, Derivative of Gentamicin B, Compared to That of Amikacin
- Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
- Chemotherapeutic Evaluation of 5-Episisomicin (Sch 22591), a New Semisynthetic Aminoglycoside
- Comparative in vitro activity of ceftibuten (Sch 39720) against bacterial enteropathogens.
- Comparison of 5-Episisomicin (Sch 22591), Gentamicin, Sisomicin, and Tobramycin in Treatment of Experimental Pseudomonas Infections in Mice
